1. P34 Ocrelizumab treatment satisfaction in patients with suboptimal response to previous disease-modifying therapies. Issue 4 (April 2020) Authors: Van Wijmeersch, B.; Buffels, R.; Clinch, S.; Eggebrecht, J.; Kuhelj, R.; Wei, W.; Vermersch, P. Journal: Clinical neurophysiology Issue: Volume 131:Issue 4(2020:Apr.) Page Start: e195 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗